Atossa Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Atossa Therapeutics, Inc. (ATOS) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents71.0888.46110.89136.3839.5512.6910.38
Cash & Short-Term Investments71.0888.46110.89136.3839.5512.6910.38
Accounts Receivable0.000.000.741.070.640.000.52
Inventory0.001.495.250.000.000.000.00
Other Current Assets3.370.061.212.491.810.030.03
Total Current Assets74.4692.22118.20141.2442.7713.5811.55
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.020.040.080.05
Long-Term Investments0.001.714.700.000.000.000.00
Intangible Assets0.000.000.000.000.010.000.00
Other Non-Current Assets1.992.320.640.020.020.760.02
Total Non-Current Assets1.994.035.340.020.000.910.17
Total Assets76.4496.25123.53141.2642.8414.4911.72
Current Liabilities
Accounts Payable0.680.812.971.721.591.270.53
Accrued Liabilities1.251.262.581.391.060.000.00
Other Current Liabilities4.291.800.020.0213.010.010.98
Total Current Liabilities4.975.245.573.1315.671.322.92
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.000.010.00
Other Non-Current Liabilities0.000.000.000.000.000.000.00
Total Non-Current Liabilities0.000.000.000.000.000.010.00
Total Liabilities4.975.245.573.1315.671.332.92
Stockholders' Equity
Common Stock23.4922.7922.7922.798.560.000.00
Retained Earnings-211.79-186.29-156.19-129.23-111.90-94.07-76.83
Treasury Stock-1.481.480.000.000.000.000.00
Additional Paid-in Capital261.26255.99251.37244.580.00105.5884.58
Shares Outstanding8.618.358.448.440.000.000.00
Total Stockholders' Equity71.4891.02117.96138.1427.1713.168.81
Total Liabilities & Equity76.4496.25123.53141.260.0014.4911.72